2025-2026

CHBRP generally analyzes introduced bills prior to their first Senate or Assembly Health Committee hearing. Completed CHBRP analyses (and the analyzed bill language) are available at http://chbrp.org/analysis/completed-analyses. As bills move through the Legislature, bills may be significantly amended, which may alter CHBRP’s projected impacts. The table, below, indicates the version of each analyzed bill and the extent to which CHBRP’s analyses remain relevant. Amended bill language and the bill status are available at http://leginfo.legislature.ca.gov/.

CHBRP’s analyses may still be of use after the legislative cycle concludes in order to inform future legislation, the implementation of analyzed legislation that is signed into law or included in California’s budget, and the ongoing evaluation of relevant health benefit mandates and repeals.

Bill Number Bill Author Bill Title Current location Bill amended since CHBRP analysis? Which portions of CHBRP’s analysis remain relevant?
AB 298 Bonta
Cost Sharing
View status on https://leginfo.legislature.ca.gov/ No All portions of CHBRP's analysis remain relevant.
AB 350 Bonta
Fluoride treatment
View status on https://leginfo.legislature.ca.gov/ No All portions of CHBRP's analysis remain relevant.
AB 546 Caloza
HEPA purifiers and filters
View status on https://leginfo.legislature.ca.gov/ No All portions of CHBRP's analysis remain relevant.
SB 40 Wiener
Insulin
View status on https://leginfo.legislature.ca.gov/ Yes Bill amended – 4/07/2025 – Amended language would delay implementation for the small group and individual markets until 2027 and would state that plans and policies would be required to cover at least one of each drug type of insulin without step therapy. All portions of CHBRP’s analysis remain relevant.
SB 257 Wahab
PARENT Act
View status on https://leginfo.legislature.ca.gov/ All portions of CHBRP's analysis remain relevant.
Bill Number Bill Author Bill Title Current location Amended Which portions of CHBRP’s analysis remain relevant?